ExclusiveFDA LOSES War On Ivermectin #frontpageshow #frontpageexclusive

Finally, on March 21st, the U.S. Food and Drug Administration, the FDA, agreed to remove social media posts and webpages that urge people to stop taking ivermectin to treat COVID-19 after being taken to court over the matter. According to a settlement that was filed with a federal court in southern Texas, the FDA has already removed a page that says, No. Within 21 days, the FDA will remove another page titled, The page currently states, The FDA has not authorized or approved ivermectin for use in preventing or treating COVID-19 in humans or animals. It also says that data do not show that ivermectin is effective against COVID-19. This contrasts with some studies that show ivermectin is effective against the illness. In the settlement, the FDA also agreed to delete multiple social media posts that strongly oppose ivermectin. These posts include one that stated, In exchange, doctors who sued the agency dismissed their claims. Dr. Mary Talley Bowden said, Dr. Bowden also said, Ivermectin was approved by the FDA in 1996 to treat several conditions. Often, doctors prescribe medicine that is off-label or for a different purpose than it is approved for in the United States. After some doctors prescribed ivermectin for COVID-19, the FDA ramped up its campaign. Dr. Bowden and two other doctors sued the FDA. They argued that the FDA's actions went beyond the authority that was granted to the FDA by Congress. U.S. District Judge Jeffrey Brown dismissed the case in 2022. He ruled that the FDA did not act outside its authority. However, an appeals court in 2023 ruled in favor of the doctors, and found that the agency has identified no authority allowing it to recommend that consumers stop taking medicine. So what is the truth about ivermectin? The first reports of ivermectin's anti-cancer properties came in 1995. Ivermectin is a Nobel Prize-winning anti-parasite drug. Two French researchers found that ivermectin could reverse multi-drug resistance in tumors. The drug targets tumor stem cells and promotes cancer death. Ivermectin also enhances chemotherapy and radiation therapy effects. It has a broad impact on the immune system, increasing immune offense against cancers. It also inhibits cancer cell cycles, preventing new cancer cells. The drug promotes the killing of cancer cells by inducing mitochondrial stress. By preventing blood vessels from forming near cancer cells, it prevents cancer from surviving. Many studies have found that ivermectin has impressive potential as an anti-cancer drug. However, there are few clinical studies on the use of ivermectin for cancer. There was a study that followed three children with acute myeloid leukemia. Leukemia is an aggressive cancer that progresses rapidly if left untreated. After conventional chemo failed, all three children were treated with ivermectin. While all patients eventually succumbed to the disease, two children saw temporary improvement in their symptoms. This was noteworthy given the cancer's rapid progression. The third patient had no response to ivermectin. Another Japanese study followed three patients with different cancers, breast, bone, and lung. They were on a combination of ivermectin and other drugs. The drugs included anti-cancer hormonal therapy. For two patients, ivermectin was added last in the therapeutic combination, with doctors observing significant symptom improvements. The authors noted that one patient's symptoms were relieved soon after adding ivermectin. The other patient was prescribed ivermectin alongside other drugs. After one treatment cycle, he could come to the clinic on foot by himself. Dr. Peter P. Lee, the Chair of Immunooncology at the City of Hope, is a leading researcher in the United States on ivermectin as an immunotherapeutic drug for cancer. Anti-cancer therapeutics such as chemotherapy and radiation therapy focus on damaging the DNA of cancer cells. They kill the cells. However, these treatments also kill immune cells and they suppress the immune system. Dr. Lee added, ivermectin has a lot of promise for cancer, but probably not as a standalone treatment. Let's look at another example of how ivermectin could extend the life of cancer patients. In November of 2020, Rick Alderson, a retired sawmill worker, was diagnosed with terminal colon cancer. After suffering excruciating pain in his intestines for months, a gastroenterologist found a large tumor in his rectum. The doctor told him and his wife that he only had six months left. In fact, to the oncologist, Alderson was a dead man walking. Doctors were against starting him on treatment due to Alderson's age and cancer severity. Yet the Alderson's determined that their fate was in God's hands and they decided to do whatever they could. Alderson got started with 10 rounds of radiation therapy. A month later, he started chemotherapy. By the time Alderson started treatment, his colon cancer had metastasized and spread to his liver where he had 25 tumors. Alderson said in an interview with the Cancer Box, which is a cancer diagnosis blog, I was off their charts. Due to concerns about COVID-19 and the ongoing pandemic, Alderson started looking into preventative medication and he found ivermectin. Further research showed that the drug was relatively safe and could likely enhance chemotherapy and radiation therapy effectiveness. So in February of 2021, he began taking ivermectin. Ten days later, his CEA levels suddenly dropped. Come March, the number dropped even more. By mid-summer, it had fallen into a normal range. Of the 25 tumors in his liver, only three remained. Alderson lived another two years before losing his life to liver failure due to his three remaining liver tumors. His wife said his life was definitely extended. She attributed Alderson's survival beyond his prognosis to his success with ivermectin and the chemotherapy drug. To remark, ivermectin was instrumental.